Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2022 Jan 28;19(3):1520.
doi: 10.3390/ijerph19031520.

The Prevalence of Antimicrobial Resistant Neisseria gonorrhoeae in Papua New Guinea: A Systematic Review and Meta-Analysis

Affiliations
Meta-Analysis

The Prevalence of Antimicrobial Resistant Neisseria gonorrhoeae in Papua New Guinea: A Systematic Review and Meta-Analysis

Barne Willie et al. Int J Environ Res Public Health. .

Abstract

Neisseria gonorrhoeae antimicrobial resistance (NG AMR) has become an urgent concern globally. The World Health Organization, the United States of America Centers for Disease Control, and other regulators have called to improve resistance-testing methods to enhance NG AMR surveillance. NG AMR surveillance remains critical in informing treatment; unfortunately, this is often lacking in settings with limited resources, such as Papua New Guinea (PNG). We conducted a systematic review and a prevalence meta-analysis, and provided an overview of NG AMR in PNG. We showed the lack of NG AMR data in the last decade, and emphasized the need for NG AMR surveillance in PNG. Since NG AMR testing by the NG culture method is unreliable in PNG, we suggested using molecular tests to complement and enhance NG AMR surveillance.

Keywords: Neisseria gonorrhoea; Papua New Guinea; antimicrobial resistance; surveillance.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
PRISMA [19] flow chart of article search, article inclusion and exclusion, and the number of studies included in this study-systematic review and meta-analysis.
Figure 2
Figure 2
Penicillinase-producing N. gonorrhoeae positive strain prevalence estimate. Forest plots include the authors name, year of publication, year when samples were collected, number of cases reported, sample size employed, proportion, 95% CI, and sample weights. Diamond symbol at the bottom is the pooled estimate.
Figure 3
Figure 3
Chromosomally-mediated resistance to penicillin prevalence estimate.
Figure 4
Figure 4
Tetracycline resistance prevalence estimate.
Figure 5
Figure 5
Quinolone (ciprofloxacin) resistance prevalence estimate.
Figure 6
Figure 6
Spectinomycin resistance prevalence estimate.
Figure 7
Figure 7
Cephalosporin resistance prevalence estimate.

Similar articles

Cited by

References

    1. Whiley M.D., Goire N., Lahra M.M., Donovan B., Limnios E.A., Nissen D.M., Sloots P.T. The ticking time bomb: Escalating antibiotic resistance in Neisseria gonorrhoeae is a public health disaster in waiting. J. Antimicrob. Chemother. 2012;67:2059–2061. doi: 10.1093/jac/dks188. - DOI - PubMed
    1. Unemo M., Shafer M.W. Antimicrobial Resistance in Neisseria gonorrhoeae in the 21st Century: Past, Evolution, and Future. Clin. Microbiol. Rev. 2014;27:587–613. doi: 10.1128/CMR.00010-14. - DOI - PMC - PubMed
    1. Młynarczyk-Bonikowska B., Majewska A., Malejczyk M., Młynarczyk G., Majewski S. Multiresistant Neisseria gonorrhoeae: A new threat in second decade of the XXI century. Med. Microbiol. Immunol. 2020;209:95–108. doi: 10.1007/s00430-019-00651-4. - DOI - PMC - PubMed
    1. Whiley D.M., Lahra M.M., Unemo M. Prospects of untreatable gonorrhea and ways forward. Future Microbiol. 2015;10:313–316. doi: 10.2217/fmb.14.138. - DOI - PubMed
    1. World Health Organization Global Action Plan to Control the Spread and Impact of Antimicrobial Resistance in Neisseria Gonorrhoeae. [(accessed on 14 December 2020)];2012 Available online: https://apps.who.int/iris/handle/10665/44863.

Publication types

Substances